Yatharth Hospital & Trauma Care Services Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company has delivered good profit growth of 50.5% CAGR over last 5 years
- Company has delivered good sales growth of 29.1% CAGR over last 5 years
- Working capital cycle has improved - days down from 832 to 221
- Company comfortably covers its interest (12.3x coverage)
- Company maintains a comfortable, low leverage position
CONS
- Recent results are weak - TTM profit is down 82.1% versus prior year
- Promoter holding has decreased over last 2 years: -10.7pp
- Free cash flow has been persistently negative
- Equity base is being diluted - shares outstanding up 47.1%
- Valuation is stretched - P/E of 98.8 is well above its own 5-year median (46.7)
- Operating margins have contracted to 24.6% from 29.1%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | 8960.00 | 61.66 | 128831.05 | 0.22 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| MAXHEALTH | 1036.50 | 69.24 | 100883.61 | 0.19 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| MANIPALHOS | 729.95 | 107.60 | 96015.96 | 0.00 | 2434.30 | — | 30906.30 | — | 13.93 | 23.83 |
| FORTIS | 911.90 | 65.70 | 68844.63 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| ASTERDM | 780.05 | 213.36 | 67994.81 | 0.00 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.46 | 19.53 |
| MEDANTA | 1479.75 | 71.54 | 39786.30 | 0.03 | 157.25 | -1.09 | 1304.05 | 26.50 | 19.38 | 21.99 |
| NH | 1888.80 | 47.30 | 38599.67 | 0.24 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| LALPATHLAB | 1919.45 | 59.45 | 32217.74 | 1.07 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| KIMS | 764.80 | 157.23 | 32122.10 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| AGARWALEYE | 514.20 | 109.87 | 16301.49 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 16.14 | 27.75 |
| VIJAYA | 1496.85 | 82.23 | 15417.21 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.28 | 42.66 |
| YATHARTH | 989.25 | 52.61 | 9531.85 | 0.00 | 454.23 | 8.04 | 3926.54 | 52.33 | 13.30 | 23.35 |
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,023 | 1,101 | 1,017 | 1,056 | 1,190 | 1,129 | 1,104 | 1,120 | 1,301 | 137 | 158 | 164 | 1,763 | |
| 788 | 836 | 765 | 813 | 903 | 872 | 839 | 851 | 999 | 110 | 122 | 125 | 1,516 | |
| Operating Profit | 235 | 266 | 252 | 243 | 287 | 257 | 265 | 269 | 302 | 27 | 37 | 39 | 248 |
| OPM % | 22.97% | 24.12% | 24.80% | 22.98% | 24.11% | 22.75% | 23.97% | 24.03% | 23.21% | 19.63% | 23.11% | 23.91% | 14.04% |
| 4 | 33 | 48 | 51 | 26 | 18 | 32 | 41 | 73 | 6 | 5 | 7 | 133 | |
| Interest | 24 | 16 | 1 | 2 | 1 | 2 | 1 | 2 | 2 | 0 | 1 | 4 | 53 |
| Depreciation | 32 | 32 | 40 | 31 | 40 | 48 | 52 | 47 | 47 | 6 | 9 | 10 | 101 |
| Profit before Tax | 239 | 299 | 300 | 293 | 313 | 275 | 296 | 310 | 375 | 27 | 32 | 31 | 381 |
| Tax % | 34.72% | 29.63% | 29.62% | 10.51% | 26.07% | 25.80% | 24.87% | 29.40% | 27.61% | 22.41% | 25.57% | 23.41% | 26.04% |
| Net Profit | 156 | 210 | 211 | 262 | 231 | 204 | 223 | 219 | 271 | 21 | 24 | 24 | 282 |
| 2.38 | 2.90 | 2.74 | 3.32 | 2.70 | 2.37 | 2.60 | 2.55 | 2.81 | 2.14 | 2.48 | 2.47 | 2.92 |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 102 | 133 | 165 | 299 | 372 | 420 | 456 | 592 | 636 | |
| 82 | 101 | 120 | 214 | 265 | 301 | 324 | 446 | 508 | |
| Operating Profit | 20 | 31 | 45 | 85 | 106 | 119 | 132 | 146 | 127 |
| OPM % | 19.43% | 23.70% | 27.03% | 28.48% | 28.62% | 28.33% | 29.02% | 24.61% | 20.05% |
| 0 | 0 | 1 | 1 | 2 | 14 | 9 | 23 | 32 | |
| Interest | 7 | 14 | 13 | 13 | 10 | 6 | 4 | 11 | 11 |
| Depreciation | 8 | 15 | 14 | 13 | 13 | 13 | 19 | 30 | 36 |
| Profit before Tax | 6 | 3 | 18 | 60 | 86 | 113 | 119 | 127 | 128 |
| Tax % | 50.40% | 72.39% | 30.52% | 30.23% | 24.96% | 25.74% | 26.58% | 24.98% | 24.53% |
| Net Profit | 3 | 1 | 12 | 42 | 64 | 84 | 88 | 95 | 96 |
| EPS | 1.78 | 0.49 | 1.88 | 6.46 | 9.83 | 9.78 | 9.10 | 9.90 | — |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 29%
- 3 Years:
- 17%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 51%
- 3 Years:
- 14%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 37%
- 1 Year:
- 22%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 24%
- 3 Years:
- 10%
- Last Year:
- 6%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 66 | 66 | 86 | 96 | 96 |
| 39 | 40 | 53 | 46 | 111 | 751 | 1,429 | 1,523 | |
| 120 | 106 | 107 | 95 | 87 | 2 | 4 | 212 | |
| Trade Payables | 12 | 11 | 13 | 16 | 11 | 12 | 11 | 48 |
| 10 | 28 | 23 | 64 | 52 | 28 | 90 | 124 | |
| Total Liabilities | 197 | 202 | 211 | 286 | 326 | 878 | 1,631 | 2,004 |
| 146 | 134 | 132 | 122 | 121 | 133 | 161 | 393 | |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 153 | 18 |
| 28 | 33 | 34 | 47 | 47 | 67 | 234 | 534 | |
| 2 | 3 | 3 | 2 | 3 | 4 | 9 | 9 | |
| 0 | 0 | 0 | 0 | 0 | 143 | 171 | 206 | |
| Cash & Bank | 0 | 1 | 1 | 2 | 13 | 227 | 299 | 201 |
| 20 | 30 | 42 | 112 | 143 | 304 | 603 | 643 | |
| Total Assets | 197 | 202 | 211 | 286 | 326 | 878 | 1,631 | 2,004 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 21 | 26 | 26 | 36 | 58 | 16 | 95 | 95 | |
| Cash from Investing | -39 | -8 | -4 | -18 | -9 | -167 | -557 | -383 |
| Cash from Financing | 21 | -20 | -23 | -7 | -6 | 241 | 602 | 215 |
| 2 | -4 | -1 | 1 | 11 | 89 | 140 | -73 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-04 - We hereby submit the Newspaper Publication of the Notice for the 19th Annual General Meeting of the Company, along with the e-voting information.
2026-09-03 - We hereby submit Business Responsibility and Sustainability Reporting (BRSR) of the Company for FY 2025-26.
2026-09-03 - We hereby submit Notice of 19th Annual General Meeting of the Company.
2026-08-28 - The Exchange has sought clarification from Yatharth Hospital & Trauma Care Services Limited with respect to recent news item captioned Aster, Advent eye controlling stake in Yatharth Hospital, says report; shares rise 4.5%. The response from the Company is attached.
2026-08-28 - The Exchange has sought clarification from Yatharth Hospital & Trauma Care Services Limited with respect to recent news item captioned Aster, Advent eye controlling stake in Yatharth Hospital, says report; shares rise 4.5%. The response from the Company is awaited.
2026-08-22 - We hereby submit Newspaper Advertisement for information regarding the 19th Annual General Meeting of the Company.
2026-08-21 - We hereby submit Intimation of the date of 19th Annual General Meeting of the Company.
2026-08-18 - We hereby submit Earnings Call Transcript Q1FY27.
2026-08-13 - We hereby submit Monitoring Agency Report for the quarter ended June 30, 2026 (IPO).
News
Recent coverage and analyst commentary for YATHARTH
Loading news…
AI Stock Analyst
Yatharth Hospital & Trauma Care Services Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account